| One of the associated stream of Pharmaceutical | | | | can be cured by clinical applications to a maximum |
| engineering is Biopharmaceuticals. It utilizes the | | | | extent. |
| biotechnology concepts to manufacture medicines. | | | | Nearly all the drugs production uses the concept of |
| These plants take into account that living organisms | | | | biotechnology. Life span can be augmented by the |
| and botanical sources which are rich in substances | | | | advancement of pathogenesis which can give |
| used in making several medicines. | | | | answers to almost all life taking diseases. Using |
| Pharmaceutical proteins which are recombinant and | | | | biopharma, effective treatment of traumas and |
| secure are greatly in demand. Before two decades, | | | | several diseases are possible but it needs huge |
| Biotechnology was not so developed but now its | | | | investment cost and a lengthy development time. |
| ruling the world market. Red-blood-cell stimulating | | | | However production costs can be greatly reduced by |
| agents, insulin, growth hormones etc are greatly used | | | | producing biopharmaceuticals in plants with an |
| in the prevention of numerous diseases like orphan | | | | advantage of greater safety. Blood disorders and |
| diseases, multiple sclerosis, arthritis etc. | | | | oncology which are a threat to mankind can be |
| Around 80 biopharmaceutical plants are already | | | | healed by vaccines and anti-infective which are made |
| present in the market till now and another 500 are | | | | possible by biopharmaceuticals. |
| yet to launch as soon as possible. They are | | | | Several medical agencies are now publishing the |
| undergoing development procedures at different | | | | strategies for the effective production of substances |
| clinical level. The recombinant antibodies (rAbs) and its | | | | which are biologically active. These strategies are |
| derivatives are in the topmost position for clinical | | | | highly useful in production process starting from the |
| uses. The latest techniques have given a scope to | | | | development of biopharma genetic to its |
| expand fully human and humanized antibodies which | | | | manufacture and control measures. These highly |
| have greater healing properties. 40% of entire | | | | effective strategies are attracting more and more |
| manufacture of biopharmaceuticals is done alone by | | | | investors and also enhancing research process. |
| highly potential and restorative monoclonal antibodies | | | | Thus we can say Biopharmaceuticals is a branch of |
| (Mabs). Major medical areas like cardiovascular | | | | Pharmaceutical engineering which is creating wonders |
| disorders, transplants, auto immunity and even cancer | | | | in medical world. |